BioInVision exhibited MERLIN work at the International Society for Stem Cell Research (ISSCR) 2015 meeting in Stockholm, Sweden, 24 – 27 June.
Author Archive for: merlin_admin
This author has yet to write their bio.Meanwhile lets just say that we are proud merlin_admin contributed a whooping 50 entries.
Entries by merlin_admin
Our sister project REDDSTAR and Leiden University Medical Center are co-organizing EU MSC2 2015, a meeting in Leiden, NL on September 7th and 8th to bring together nine EU-funded, mesenchymal stromal cell-focussed consortia. Projects include: REDDSTAR, REACH, RETHRIM, Stellar, MERLIN, Nephstrom, SCIENCE, VISICORT and Adipoa-2. This two day, interactive meeting will be held at the […]
Two new related publications from EMC are available here. The publications look at whether mesenchymal stromal cells are immune cells, and how mesenchymal stem cells immune cells in different ways.
MERLIN brochure and flyer are now available here.
The International Society for Stem Cell Research (ISSCR) has launched a new website to help patients and their families make informed decisions about stem cell treatments, clinics and their health. The site includes extensive information on clinical trials and how science becomes medicine. You can visit the site here: http://www.closerlookatstemcells.org/
The hepatology team at the John Radcliffe Hospital in Oxford are hosting an Open Forum for patients, carers, medical professionals on the latest developments in liver research on Wednesday 29 April. More information is available on the PSC Support page.
Congratulations to Dr. Elliman and his team at Orbsen Therapeutics for their nomination for Spin-Out Company Impact Award, an annual Knowledge Transfer Ireland Impact Award. “We are honoured to be nominated for KTI Spin-out Company of the Year. It recognises the huge efforts made by our own research team and our network of research partners to move […]
You can read more about our work in the first year of the project here. .
The MERLIN team met in Rotterdam 12 – 13 February 2015 to discuss progress in the first year of the project, and to make plans for the coming year. We’ve learned more about how MSC work in our in vitro and in vivo studies, and planning is well underway for the planned clinical trial with PSC patients. […]
Steve Elliman of Orbsen Therapeutics has been interviewed by EuroStemCell – you can find videos of the interview by clicking here.
- The MERLIN study “Epigenetic changes in umbilical cord mesenchymal stromal cells upon stimulation and culture expan… t.co/apCTuxvBqG Time ago 9 Hours via Twitter Web Client
- Looking for vacancies in the #stemcell arena? Have you visited t.co/5snVj6rUPV or t.co/XYqojq2jsf? Best of luck! Time ago 3 Days via Twitter Web Client
- An excellent video (Thanks @LiverTrust) overviewing #PSC including the currently-available treatments: immunosuppre… t.co/kaLFLe6fWB Time ago 6 Days via Twitter Web Client
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.